Take the Money and Run: 3 Overbought Stocks to Sell ASAP

Group 1: Coupang (CPNG) - Coupang operates retail businesses through mobile applications and websites, offering a wide range of products in South Korea [2] - CPNG stock has returned over 43% year-to-date, with a relative strength indicator (RSI) of over 84, indicating it may be overbought [2] - The stock trades at 1.66X trailing-year revenue, above the sector median of 0.67X, with projected revenue of $29.17 billion for the current fiscal year, up 19.6% from $24.38 billion in 2023 [3] Group 2: Argan (AGX) - Argan specializes in engineering and construction services for the power generation market, benefiting from momentum in the green energy sector [5] - AGX stock has gained almost 30% since the beginning of the year, with a recent surge of 22% in the last five sessions, and an RSI of 80.75, indicating it may be overbought [5] - The stock trades at a sales multiple of 1.44X, compared to the sector median of 0.76X, with anticipated sales of $724.35 million for the current fiscal year, up 26.3% from $573.33 million last year [6] Group 3: Janux Therapeutics (JANX) - Janux Therapeutics focuses on developing immunotherapies for cancer, with a core product in Phase 1 trials for metastatic castration-resistant prostate cancer [7] - JANX stock has increased nearly 359% year-to-date, with a recent gain of almost 28% in the past five sessions, and an RSI of 72.59, suggesting it may be overbought [7][8] - The stock trades at nearly 278X trailing-year revenue, with a projected revenue target of $5 million for fiscal 2024, which is below the previous year's revenue of $8.08 million [8]